42
Participants
Start Date
August 31, 2012
Primary Completion Date
December 31, 2014
Study Completion Date
December 31, 2014
Rilonacept
12 weeks of treatment with rilonacept (subcutaneous injection with a loading dose of 320 mg, followed by 160 mg/wk)
Placebo
Twelve weeks of treatment with placebo (subcutaneous injection of normal saline with a loading dose of 320 mg, followed by 160 mg/wk)
Vanderbilt University Medical Center, Nashville
University of Colorado Clinical and Translational Research Center (CTRC) Outpatient Clinic, Aurora
University of Colorado, Denver
OTHER